Last update 12 Nov 2024

Asocura Pharmaceuticals Suzhou Co., Ltd.

Private Company | Subsidiary Company|
2017|
Jiangsu Sheng, China
|
www.aso-cura.com

Overview

Tags

Nervous System Diseases
Other Diseases
Congenital Disorders
ASO

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases8
Neoplasms2
Top 5 Drug TypeCount
ASO11
Top 5 TargetCount
DMD exon 45(Dystrophin exon 45)1
PD-1(Programmed cell death protein 1)1
ATXN3(ataxin 3)1
pendrin(solute carrier family 26 member 4)1
DMD exon 51(Dystrophin exon 51)1

Related

11
Drugs associated with Asocura Pharmaceuticals Suzhou Co., Ltd.
FYHL-001
Target
pendrin
Mechanism
pendrin modulators
Active Org.
Asocura Pharmaceuticals Suzhou Co., Ltd.
Originator Org.
Asocura Pharmaceuticals Suzhou Co., Ltd.
Active Indication
Deafness
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
FYCR-001
Target
PD-1
Mechanism
PD-1 modulators
Active Org.
Asocura Pharmaceuticals Suzhou Co., Ltd.
Originator Org.
Asocura Pharmaceuticals Suzhou Co., Ltd.
Active Indication
Liver Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
FYNM-001
Target
DMD exon 51
Mechanism
DMD exon 51 modulators
Active Org.
Asocura Pharmaceuticals Suzhou Co., Ltd.
Originator Org.
Asocura Pharmaceuticals Suzhou Co., Ltd.
Active Indication
Muscular Dystrophy, Duchenne
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Asocura Pharmaceuticals Suzhou Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Asocura Pharmaceuticals Suzhou Co., Ltd.
Login to view more data
100 Deals associated with Asocura Pharmaceuticals Suzhou Co., Ltd.
Login to view more data
100 Translational Medicine associated with Asocura Pharmaceuticals Suzhou Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
11
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
FYNM-005
 ( APP )		Alzheimer Disease
More
Preclinical
FYNM-006
 ( ATXN3 )		Cerebellar Ataxia
More
Preclinical
FYNM-004
 ( Nav1.7 )		Pain
More
Preclinical
FYNM-003
 ( DMD exon 45 )		Muscular Dystrophy, Duchenne
More
Preclinical
FYCR-002
 ( p53 )		Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free